Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.52 |
| ▸ | BRD2 | P25440 | 1/20 | 0.52 |
| ▸ | INMT | O95050 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 5/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | IDE | P14735 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL717518 | 0.86 | BRD4 (0.43) | BRD4BRD2INMTMEN1KMT2A | |
| SCHEMBL82580 | 0.80 | — | — | |
| SCHEMBL916157 | 0.78 | BRD4 (0.50) | BRD4BRD2INMTKMT2ACRBN | |
| Bromide SCHEMBL7186245 | 0.78 | BRD4 (0.50) | BRD4BRD2INMTKMT2ACRBN | |
| Fluoride SCHEMBL20741987 | 0.78 | BRD4 (0.50) | BRD4BRD2INMTKMT2ACRBN | |
| SCHEMBL11970846 | 0.77 | — | — | |
| SCHEMBL19345926 | 0.75 | BRD4 (0.48) | BRD4BRD2INMTMEN1KMT2A | |
| SCHEMBL8272670 | 0.73 | BRD4 (0.52) | BRD4BRD2INMTMEN1KMT2A | |
| SCHEMBL762771 | 0.73 | — | — | |
| Benzene SCHEMBL7856891 | 0.73 | BRD4 (0.46) | BRD4BRD2INMTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070202025-A1 | Method For Recovery Of Palladium | UNIVERSITA DEGLI STUDI DI CAGLIARI (IT) | 2007-08-30 | — | — | US | disclosed |
| US-20070202025-A1 | Method For Recovery Of Palladium | UNIVERSITA DEGLI STUDI DI CAGLIARI (IT) | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070202025-A1 | Method For Recovery Of Palladium | DDT, COMT, DDO | BRD4 1598/4885BRD2 1726/4885INMT 303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.